Development of specialized carriers capable of delivering effective RNAi and siRNA gene therapy
New cationic carriers must be molecularly designed to enable selective RNAi and siRNA transport and administration. Because at some time, the carriers will have to be removed from the cells and perfused out of the body, sophisticated, temporarily controllable biodegradable carriers are necessary. This indicates that the degradation process must be well regulated and possibly in several steps to destroy the carrier in a controlled manner.Moreover, multifunctional cationic carriers must be molecularly designed to carry and steer two independent kinds of siRNAs delivered at two very different rates. This allows sequential treatment of some diseases. Nanosized carriers must be enhanced to provide sufficient stability for the therapeutic duration of the system. In addition, there is the recurring issue of cationic carrier toxicity to be addressed in the near future. Despite the courageous and robust field efforts, a lot of difficulties still need to be resolved.